SummitTX Capital’s Zymeworks ZYME Stock Holding History

SummitTX Capital’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.05M	Buy	321,427 +97,159	+43%	+$2.3M	0.25%	94
2025 Q4	$5.9M	Buy	+224,268	New	+$4.89M	0.18%	137

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SummitTX Capital's ZYME Position: Q1 2026 in Review

SummitTX Capital increased its Zymeworks (ZYME) stake by 43% in Q1 2026, buying an estimated $2.3M and bringing the position to 321,427 shares worth $8.05M. The position accounts for 0.25% of the portfolio, ranked #94.

SummitTX Capital first reported a position in ZYME in Q4 2025 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

SummitTX Capital held 321,427 shares of Zymeworks worth $8.05M as of Q1 2026.
SummitTX Capital bought 97,159 Zymeworks shares in Q1 2026, an estimated $2.3M.
Zymeworks made up 0.25% of SummitTX Capital's portfolio in Q1 2026, its #94 holding.
SummitTX Capital first reported a position in Zymeworks in Q4 2025 and has held it in 2 quarters since.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.